BIOSYNTECH
BioSyntech, Inc. develops biotherapeutic thermogels designed for tissue repair and delivery of therapeutic agents. Its technology platform is BST-Gel, a family of hydrogels based on chitosan, a natural biopolymer derived from crustacean shells. The company’s lead products in clinical trials include BSTCarGel for cartilage repair; BST-DermOn for wound healing; and BST-InPod for the treatment of chronic pain due to plantar fat pad atrophy in the heel and forefoot. Biosyntech has a collaboration with Nicholas Piramal India, Ltd. to involve in the clinical studies for BST-InPod, which is being developed to alleviate the chronic pain associated with foot fat pads. The company was incorporated in 1994 and is headquartered in Laval, Canada.
BIOSYNTECH
Industry:
Biotechnology Health Care Therapeutics
Founded:
1994-01-01
Address:
Laval, Quebec, Canada
Country:
Canada
Website Url:
http://www.biosyntech.com
Total Employee:
11+
Status:
Closed
Contact:
(450) 686-2437
Email Addresses:
[email protected]
Total Funding:
1.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Apache Mobile Non Scaleable Content Nginx CloudFront OpenResty Google Adsense
Investors List
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Venture Round - Biosyntech
Highland Capital Partners
Highland Capital Partners investment in Venture Round - Biosyntech
Pappas Ventures
Pappas Ventures investment in Venture Round - Biosyntech
ProQuest Investments
ProQuest Investments investment in Venture Round - Biosyntech
Official Site Inspections
http://www.biosyntech.com
- Host name: node12.zone93.ib217-116.cust.tussa.com
- IP address: 217.116.93.12
- Location: Norway
- Latitude: 59.9452
- Longitude: 10.7559
- Timezone: Europe/Oslo
